GL1X · GenesisL1 explorer

MolNFT v1 · #137810 · protein

Crystal structure of crenezumab Fab in complex with abeta

5VZY · Crenezumab Fab heavy CHAIN,IMMUNOGLOBULIN gamma-1 heavy…: “Crystal structure of crenezumab Fab in complex with abeta”. X-ray diffraction, 4 pockets (best druggability 0.50). MolNFT v1 #137810 on GenesisL1: 3D structure, binding…

PDB
5VZY
Type
protein
Length
436 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Crenezumab Fab heavy CHAIN,IMMUNOGLOBULIN gamma-1 heavy chain; Crenezumab Fab light…
UniProt
P0DOX5, Q0KKI6, P05067
Pockets
4 · best druggability 0.50

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HCrenezumab Fab heavy CHAIN,IMMUNOGLOBULIN gamma-1 heavy chainprotein2067% helix, 51% strandP0DOX5
LCrenezumab Fab light CHAIN,IMMUNOBLOBULIN light chainprotein2186% helix, 50% strandQ0KKI6
AAmyloid beta A4 proteinprotein120% helix, 0% strandP05067

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12400.500.7540empty
21550.450.7627empty
31230.360.7326empty
4700.300.7416empty

Interfaces

3 interfaces between chains.

  • H–L · 1516 Ų buried · 10 hydrogen bonds · protein-protein
  • H–A · 535 Ų buried · 7 hydrogen bonds · protein-protein
  • L–A · 467 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5VZY · Crystal structure of crenezumab Fab in complex with Abeta · the same entry in another collection · chain H against H, TM-score 1.00
  • P05067 · AlphaFold monomer V2.0 prediction for amyloid-beta precursor protein (P05067) · a predicted model of the same protein · chain A against A, TM-score 0.29

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.